Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADXS11-001 in CIN 2/3
NCT01116245Phase 2Terminated
- Sponsor
- Advaxis, Inc.
- Start
- Apr 2010
- Primary completion
- Dec 2013
- Modality
- Gene Editing, Gene Silencing, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of axalimogene filolisbac in cervical intraepithelial neoplasia (CIN), sponsored by Advaxis, Inc.. Started Apr 2010; status: terminated.
02
Drugs
axalimogene filolisbac
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT01116245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116245.